011040 — Kyung Dong Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapNeutral

Market Cap
KR₩149bn
Enterprise Value
KR₩145bn
Revenue
KR₩196bn

Annual balance sheet for Kyung Dong Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	50,043	45,128	32,075	30,913	46,998
Net Total Accounts Receivable
Net Total Receivables	21,508	25,485	20,664	24,335	21,994
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	103,208	102,981	89,749	101,829	112,758
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	89,880	95,097	73,646	74,796	87,377
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	291,974	310,478	292,971	302,873	321,895
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	25,364	50,127	59,027	78,428	69,585
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	32,153	53,274	64,792	82,812	93,538
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	259,821	257,204	228,179	220,061	228,357
Total Liabilities & Shareholders' Equity	291,974	310,478	292,971	302,873	321,895
Total Common Shares Outstanding